Does Mississippi Medicaid Cover Wegovy or Zepbound?
Mississippi (MS) GLP-1 access depends on three state-specific policy questions before it ever gets to pricing: does Mississippi Medicaid cover weight-loss GLP-1s, has Mississippi expanded Medicaid under the ACA, and does the state employee health plan cover them. Answering those first tells you whether you're likely working with insurance or planning for cash-pay.
Mississippi Medicaid GLP-1 coverage: what the state's own documents say
The Mississippi Division of Medicaid covers Saxenda and Wegovy (injection and oral; ages 12 and up) plus Foundayo (oral) and Zepbound (ages 18 and up) as preferred agents with prior authorization (adult BMI 30 or higher, or 27 to 29 with a weight-related condition; one agent at a time; 12-month initial authorization); Contrave, Qsymia and phentermine are not covered.
Checked September 20, 2026 against: medicaid.ms.gov, medicaid.ms.gov, medicaid.ms.gov, medicaid.ms.gov.
Mississippi state employee health plan: what the plan's own documents say
The plan document revised January 1, 2026 says 'Wegovy and other drugs used for weight loss and/or obesity are a plan exclusion' (Wegovy is considered by prior authorization only for cardiovascular risk reduction and MASH, Zepbound only for moderate-to-severe sleep apnea) and lists weight loss drugs as not covered, while a no-cost phone-coaching program (BMI 30 or higher) is offered.
Checked September 20, 2026 against: dfa.ms.gov, dfa.ms.gov.
Notable insurers active in Mississippi (not independently verified): Blue Cross Blue Shield of Mississippi, UnitedHealthcare, Cigna.
Why GLP-1 coverage varies this much by state
Medicaid is a state-federal partnership, not a single national program. Each state Medicaid agency sets its own preferred drug list (PDL) and prior-authorization criteria within federal minimum requirements. Weight-loss drugs are not a federally mandated Medicaid benefit, so states choose independently whether to cover them - which is why only 10 of 50 states currently do (Mississippi is one of them).
State employee health plans are a useful bellwether. These plans cover hundreds of thousands of state workers and negotiate directly with pharmacy benefit managers, so their coverage decisions often signal where commercial insurers in that state are heading. North Carolina's State Health Plan, for example, ended coverage of weight-loss GLP-1s on April 1, 2024, after its board voted 4-3 to cut it citing the drugs' high cost - a case that other states and large employers have watched closely.
Medicaid expansion status shapes who even has coverage to begin with. States that haven't adopted ACA Medicaid expansion have narrower Medicaid eligibility overall, which - combined with the weight-loss GLP-1 exclusion most states apply regardless of expansion status - pushes a larger share of residents in those states toward commercial insurance, telehealth, or manufacturer self-pay as their only realistic path.
National reference pricing (same nationwide - your actual cost depends on your plan)
These prices are the same across all 50 states because manufacturer list prices, self-pay programs, and telehealth pricing don't vary by state - only insurance coverage and copay do, which is why the Mississippi-specific policy facts above matter more than the table below for predicting your actual cost.
| Drug | Covered by insurance | Manufacturer self-pay | Telehealth | Cash retail |
|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $1,349 |
| Ozempic 11.6% weight loss | $63 | - | $399 | $1,028 |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 | $449 | $1,349 |
| Zepbound 22.5% weight loss | $88 | $299 | $499 | $1,059 |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $1,069 |
| Saxenda 8.4% weight loss | $63 | - | $399 | $1,349 |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 | - | $1,099 |
| CagriSema 20.4% weight loss | $88 | $599 | - | $1,499 |
Cheapest cash-pay GLP-1 paths for Mississippi residents
Manufacturer direct prices (LillyDirect, NovoCare) are usually cheapest. Updated May 2026.
| Drug | Insurance | Mfr direct | Telehealth (brand) | Telehealth (compd) | Cash retail | Get it |
|---|---|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $249 cheapest | $1,349 | Get →ad |
| Ozempic 11.6% weight loss | $63 | - | $399 | $199 cheapest | $1,028 | Get →ad |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 cheapest | $449 | - | $1,349 | Get →ad |
| Zepbound 22.5% weight loss | $88 | $299 cheapest | $499 | $299 cheapest | $1,059 | Get →ad |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $299 cheapest | $1,069 | Get →ad |
| Saxenda 8.4% weight loss | $63 | - | $399 cheapest | - | $1,349 | Get →ad |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 cheapest | - | - | $1,099 | Get →ad |
Mississippi carrier coverage details
National carriers active in Mississippi (this list is not independently verified). Drill into each carrier's prior-auth requirements, formulary, and appeal playbook.
Frequently asked questions
Does Mississippi Medicaid cover Wegovy or Zepbound for weight loss?
Yes. The Mississippi Division of Medicaid covers Saxenda and Wegovy (injection and oral; ages 12 and up) plus Foundayo (oral) and Zepbound (ages 18 and up) as preferred agents with prior authorization (adult BMI 30 or higher, or 27 to 29 with a weight-related condition; one agent at a time; 12-month initial authorization); Contrave, Qsymia and phentermine are not covered. This was checked against Mississippi's own documents on September 20, 2026; coverage rules change often, so confirm with your plan before relying on it. Coverage for type 2 diabetes (Ozempic, Mounjaro) is a separate question. Medicare's GLP-1 Bridge, which started July 1, 2026, works separately from Medicaid and applies in every state.
Has Mississippi expanded Medicaid under the ACA?
No - Mississippi has not adopted ACA Medicaid expansion, which narrows Medicaid eligibility generally and, combined with GLP-1 weight-loss exclusion, pushes more residents toward commercial insurance, telehealth, or manufacturer self-pay programs for GLP-1 access.
Does the Mississippi state employee health plan cover Wegovy or Zepbound?
No. The plan document revised January 1, 2026 says 'Wegovy and other drugs used for weight loss and/or obesity are a plan exclusion' (Wegovy is considered by prior authorization only for cardiovascular risk reduction and MASH, Zepbound only for moderate-to-severe sleep apnea) and lists weight loss drugs as not covered, while a no-cost phone-coaching program (BMI 30 or higher) is offered. This was checked against Mississippi's own plan documents on September 20, 2026; plan terms are reset each plan year, so confirm with your plan before relying on it.